Published: 2021-06-04 20:02
Last Updated: 2021-06-12 15:16
The British Medicines and Healthcare products Regulatory Agency authorized Friday, the Pfizer-BioNTech coronavirus vaccine for children aged between 12 to 15 years old, following similar decisions from the EU and US.
The agency said in a statement that it had conducted a review of the vaccine for children, and extended the approval after it concluded that the vaccine had a positive effect in that age group.
They noted that now it is up to the country's Joint Committee on Vaccination and Immunisation (JCVI) to decide whether to go ahead and inoculate these children as part of the vaccination campaign.
This age group is already receiving the Pfizer-BioNTech jabs in the US, France and Germany.
The country's Health and Social Care department said it would provide more information after JCVI makes a decision in this regard.